ENJAYMO

Serial Number 88255430
Registration 6713660
700

Registration Progress

Application Filed
Jan 9, 2019
Under Examination
Dec 10, 2019
Approved for Publication
Jun 18, 2019
Published for Opposition
Jun 18, 2019
Registered
Apr 26, 2022

Trademark Image

ENJAYMO

Basic Information

Serial Number
88255430
Registration Number
6713660
Filing Date
January 9, 2019
Registration Date
April 26, 2022
Published for Opposition
June 18, 2019
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 26, 2022
Registration
Registered
Classes
005

Rights Holder

Bioverativ Therapeutics Inc.

03
Address
225 Second Avenue
Waltham, MA 02451

Ownership History

Bioverativ Therapeutics Inc.

Original Applicant
03
Waltham, MA

Bioverativ Therapeutics Inc.

Owner at Publication
03
Waltham, MA

Bioverativ Therapeutics Inc.

Original Registrant
03
Waltham, MA

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

Next Deadline
1010 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-04-26)
Due Date
April 26, 2028
Grace Period Ends
October 26, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

43 events
Date Code Type Description Documents
Apr 26, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 24, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 23, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 23, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 23, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 25, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 25, 2022 IUAF S USE AMENDMENT FILED Loading...
Oct 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 13, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 13, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 13, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 25, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 21, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 21, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
May 21, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 9, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 7, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 7, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 7, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 14, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 12, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 12, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
May 12, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 10, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 28, 2019 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Sep 13, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 13, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 18, 2019 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jun 18, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 18, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 29, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 15, 2019 ALIE A ASSIGNED TO LIE Loading...
May 15, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 15, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 15, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 8, 2019 ALIE A ASSIGNED TO LIE Loading...
May 3, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 1, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 1, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 1, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 25, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 30, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 12, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparation for the treatment of cold agglutinin disease
First Use Anywhere: Feb 21, 2022
First Use in Commerce: Feb 21, 2022

Classification

International Classes
005